Core Insights - Ant Insurance has upgraded its flagship health insurance product "Good Insurance" series for 2025, expanding coverage to include international departments and special needs departments of 470 top-tier hospitals across China, as well as certain private hospitals for specific diseases like cancer [1] - The upgrade enhances outpatient medication reimbursement responsibilities and adds over 1,500 advanced drugs and medical devices, including all imported drugs and nearly 400 original research drugs, promoting accessibility to high-end medical services [1][2] - The upgraded "Good Insurance" series includes three core products catering to different age groups: adults, seniors, and children, ensuring comprehensive health protection for families [1] Product Features - The 2025 version of "Good Insurance" expands the outpatient drug list to include all drugs approved by the National Medical Products Administration in 2024, allowing reimbursement for outpatient purchases during hospitalization [2] - The series introduces "exclusive family doctor services," which provide family health consultations and a dedicated advanced medicine hotline, enabling personalized medical advice and coordination with national hospitals and drug resources [2]

Group 1 - The core viewpoint of the news is that the Chinese insurance industry is responding to the government's call for high-quality development by innovating and expanding insurance products, particularly in the medical sector [1] - The new guidelines from the State Council include incorporating new medical technologies, drugs, and devices into insurance coverage, which aligns with the industry's push for product innovation [1] - Ant Financial's insurance platform, Ant Insurance, announced an upgrade to its "Good Medical Insurance" series, expanding coverage to include special departments of top-tier hospitals and enhancing the coverage of advanced medical products [1] Group 2 - The upgraded "Good Medical Insurance" products will cover three core offerings, including long-term medical insurance for adults, seniors, and children, ensuring comprehensive coverage across all age groups [1] - The 2025 version of the product will include coverage for international departments and special needs departments of 470 top-tier hospitals, as well as certain private hospitals, providing insurance for specific diseases like cancer [1] - The upgrade also expands reimbursement for outpatient medications, adding over 1,500 advanced medical products, including all imported drugs and nearly 400 original research drugs, promoting accessibility to high-end medical services [1][2]